36743-52-9

2-methoxy-5,6,6-trimethyl-5,6-dihydro-1,4,3-oxathiazine 4,4-dioxide

2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1-[2-(2-methoxyphenyl)-2-oxoethyl]-

2-Propenoic acid, 3-[1-(2-chlorophenyl)cyclopropyl]-2-ethoxy-, ethylester

2-Propenoic acid, 3-[2-[(1E)-3-hydroxy-1-propenyl]-1-cyclohexen-1-yl]-,1,1-dimethylethyl ester, (2E)-

2H-Indol-2-one, 5-chloro-3-(2,3-dimethoxyphenyl)-1,3-dihydro-

2H-Quinolizine,octahydro-1-[[2-(4-nitrophenyl)-5-(trifluoromethyl)-1H-benzimidazol-1-yl]methyl]-, dihydrochloride

2H-Tetrazole, 5-(3-bromophenyl)-2-methyl-

2H-Indol-2-one, 6-chloro-1,3-dihydro-3-(2-oxo-2-phenylethyl)-

2H-Indol-2-one, 5-[[(2-fluoro-6-nitrophenyl)methyl]sulfonyl]-1,3-dihydro-

2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1-(2-pyridinylmethyl)-

2H-Indol-2-one, 5-[[(3-chlorophenyl)methyl]sulfonyl]-1,3-dihydro-

2-Propenoic acid, 3-[3-(4-chlorophenyl)-5-(1-piperidinyl)-2-thienyl]-,methyl ester, (2E)-

2-Propenoic acid, 3-[2,4-bis(2-propenyloxy)phenyl]-, ethyl ester

2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1-[[4-(methylsulfonyl)phenyl]methyl]-

2H-Tetrazole, 2-(4-ethenylphenyl)-5-phenyl-

2H-Indol-2-one, 3-[(4-bromophenyl)imino]-1,3-dihydro-1-(3-thienyl)-,(3Z)-

2-Propenoic acid, 3-[3-[[[(1E)-2-phenylethenyl]sulfonyl]amino]phenyl]-,methyl ester, (2E)-

2-Propenoic acid, 3-[3-(1-octynyl)-2-furanyl]-, (E)-

2-Propenoic acid, 3-[3-(1H-indol-5-yl)-4-(3-pyridinylmethoxy)phenyl]-

2H-Indol-2-one, 3-[(6-chloro-3-pyridinyl)imino]-1,3-dihydro-1-phenyl-

2H-Indol-2-one, 5-acetyl-3-[(butylamino)phenylmethylene]-1,3-dihydro-

2-Propenoic acid, 3-[1-(4-nitrophenyl)-1H-pyrrol-2-yl]-

2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1-(4-pyridinyl)-

2H-Tetrazole, 2-[(phenylmethoxy)methyl]-5-(tributylstannyl)-

2-Propenoic acid, 3-[2-(cyanomethoxy)-4-nitrophenyl]-, methyl ester,(2E)-

2H-Indol-2-one,1,3-dihydro-1-(3-thienyl)-3-[[3-(trifluoromethyl)phenyl]imino]-

2-Propenoic acid, 3-[3-(1H-indazol-5-yl)-4-[(1-methylethyl)thio]phenyl]-,ethyl ester

2H-Indol-2-one, 5-chloro-1,3-dihydro-3-[(4-methylphenyl)imino]-

2-Propenoic acid, 3-[(cyclohexylcarbonyl)amino]-3-phenyl-, ethyl ester,(2E)-

2-Propenoic acid, 3-[3,4-bis[(ethoxycarbonyl)oxy]phenyl]-

2-Propenoic acid, 3-[3,4-bis[(2-methoxyethoxy)methoxy]phenyl]-, (E)-

2H-Indol-2-one, 5-[[(3-fluorophenyl)methyl]sulfonyl]-1,3-dihydro-

2H-Indol-2-one, 7-bromo-1,3-dihydro-3,3-diphenyl-

2-Propenoic acid, 3-[3-(2-propynyloxy)phenyl]-

2-Propenoic acid, 3-[2-hydroxy-4-(methoxymethoxy)phenyl]-, ethyl ester

2-Propenoic acid, 3-[3-(1H-indol-5-yl)-4-[(4-methylphenyl)thio]phenyl]-,methyl ester

2H-Indol-2-one,1,3-dihydro-3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1-[(2-methyl-4-thiazolyl)methyl]-

36743-52-9 msds

CAS No 36743-52-9 supplier

CASNo 36743-52-9 distributor

CAS # 36743-52-9 manufacturer

CAS Number 36743-52-9 safety

CAS RN 36743-52-9 wholesale

2026-10-11 Find 2-methoxy-5,6,6-trimethyl-5,6-dihydro-1,4,3-oxathiazine 4,4-dioxide,CAS No.36743-52-9,Formula:C7H13NO4S in 9CMX